Tissue Eng Regen Med.  2016 Apr;13(2):111-125. 10.1007/s13770-016-9063-8.

Gene Therapy for Bone Tissue Engineering

Affiliations
  • 1Department of Molecular Genetics, School of Dentistry, Seoul National University, Seoul, Korea.
  • 2Department of Chemical Engineering, Institute of Chemical Technology, Mumbai, India.
  • 3Department of Agricultural Biotechnology and Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul, Korea. chocs@snu.ac.kr
  • 4Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Abstract

Gene therapy holds a great promise and has been extensively investigated to improve bone formation and regeneration therapies in bone tissue engineering. A variety of osteogenic genes can be delivered by combining different vectors (viral or non-viral), scaffolds and delivery methodologies. Ex vivo & in vivo gene enhanced tissue engineering approaches have led to successful osteogenic differentiation and bone formation. In this article, we review recent advances of gene therapy-based bone tissue engineering discussing strengths and weaknesses of various strategies as well as general overview of gene therapy.

Keyword

Gene therapy; Viral vector; Non-viral vector; Bone tissue engineering; Bone morphogenetic protein

MeSH Terms

Bone and Bones*
Bone Morphogenetic Proteins
Genetic Therapy*
Osteogenesis
Regeneration
Tissue Engineering
Bone Morphogenetic Proteins
Full Text Links
  • TERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr